{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "description": "Definition not provided in the document.",
        "criteria": "Not specified in the document."
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "description": "Definition not provided in the document.",
        "criteria": "Not specified in the document."
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA",
        "description": "Definition not provided in the document. Efficacy analyses are performed on this set.",
        "criteria": "Not specified in the document."
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "description": "Definition not provided in the document. Sensitivity analyses for efficacy are performed on this set.",
        "criteria": "Not specified in the document."
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "description": "Definition not provided in the document. Safety analyses are performed on this set.",
        "criteria": "Not specified in the document."
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "PK",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "description": "Definition not provided in the document.",
        "criteria": "Not specified in the document."
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "PD",
        "instanceType": "AnalysisPopulation",
        "label": "PD",
        "description": "Definition not provided in the document.",
        "criteria": "Not specified in the document."
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age will be calculated as the integer part of the duration between the date of birth and the reference date."
      },
      {
        "id": "char_2",
        "name": "Demographics",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Demographic variables will be summarized by cohort and overall."
      },
      {
        "id": "char_3",
        "name": "Baseline Disease Characteristics",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Disease characteristics for Wilson Disease at baseline."
      },
      {
        "id": "char_4",
        "name": "Wilson Disease history",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "Participant's history of Wilson Disease."
      },
      {
        "id": "char_5",
        "name": "Medical/Surgical History",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "Participant's medical and surgical history."
      },
      {
        "id": "char_6",
        "name": "Prior medications for Wilson Disease",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Prior medications used to treat Wilson Disease, including copper-chelating therapies (penicillamine or trientine)."
      },
      {
        "id": "char_7",
        "name": "Treatment Cohort",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Participants are classified into one of two cohorts: Cohort 1 (treatment experienced) or Cohort 2 (treatment na√Øve)."
      },
      {
        "id": "char_8",
        "name": "Body Mass Index",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Body Mass Index (BMI) at baseline."
      },
      {
        "id": "char_9",
        "name": "Baseline Value",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "The baseline value for a parameter is defined as the last non-missing measurement (scheduled or unscheduled) collected on or prior to the date and time of the first dose of study drug."
      }
    ],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 9
    }
  }
}